Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - tropisetron hydrochloride, quantity: 5.65 mg (equivalent: tropisetron, qty 5 mg) - injection, solution - excipient ingredients: acetic acid; sodium acetate trihydrate; sodium chloride; water for injections - ? for the prevention of nausea and vomiting induced by cytotoxic therapy (5mg/5ml ampoule only).

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - tropisetron hydrochloride, quantity: 2.26 mg (equivalent: tropisetron, qty 2 mg) - injection, solution - excipient ingredients: acetic acid; sodium acetate trihydrate; sodium chloride; water for injections - ? for the treatment and prevention of post-operative nausea and vomiting in adults (2mg/2ml ampoule only).

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - pamidronic acid 26mg equivalent to 30.9 mg pamidronic acid disodium - powder for injection - 30 mg - active: pamidronic acid 26mg equivalent to 30.9 mg pamidronic acid disodium excipient: mannitol phosphoric acid sodium hydroxide

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - pamidronic acid 51.96mg equivalent to 61.74 mg pamidronic acid disodium;   - powder for injection - 60 mg - active: pamidronic acid 51.96mg equivalent to 61.74 mg pamidronic acid disodium   excipient: mannitol phosphoric acid sodium hydroxide

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - pamidronic acid 78.05mg equivalent to 92.75 mg pamidronic acid disodium - powder for injection - 90 mg - active: pamidronic acid 78.05mg equivalent to 92.75 mg pamidronic acid disodium excipient: mannitol phosphoric acid sodium hydroxide

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - voriconazole 200mg - powder for injection - 200 mg - active: voriconazole 200mg excipient: sulfobutyl betadex sodium water for injection - voriconazole - aft is indicated for the following fungal infections: invasive aspergillosis serious candida infections (including c. krusei), including systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia) serious fungal infections caused by scedosporium spp and fusarium spp other serious fungal infections, in patients intolerant of, or refractory to, other therapy.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - heparin sodium 100 iu/ml;   - solution for injection - 500 iu/5ml - active: heparin sodium 100 iu/ml   excipient: sodium chloride water for injection

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.669 % w/v - solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.268 % w/v - solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.268 % w/v - solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.